Lumicell is currently seeking patients to participate in the following study:
Gastrointestinal cancers—Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers.
- Collaborators include National Cancer Institute
- Clinical trial information can be found here:
Completed Clinical Trials
Lumicell completed a Phase 1 safety study at Duke University Medical Center in the lead indications of breast cancer and sarcoma. Information for the completed Phase 1 trial can be found here. Results were published in Science Translational Medicine. The paper can be found here.
The company has finished recruitment and testing in its feasibility (pilot) study under an FDA-approved IDE in breast cancer at Massachusetts General Hospital (MGH). A report will be submitted to the FDA soon. Clinical trial information can be found here ClinicalTrials.Gov